Novo Holdings A/S Insider Trading Activity

Also formerly known as Novo A/S
Average Profitability
3.41%
Insider Buys Quantity
20
Insider Buys Sum
$176.19M
Insider Sells Quantity
30
Insider Sells Sum
$313.24M

Insider Activity of Novo Holdings A/S

Biography of Novo Holdings A/S

No biography is available at this moment.

2024-03-21SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
465,021
1.1289%
$0.75$350,951-35.04%
2024-03-20SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
359,979
0.8709%
$0.73$264,081-33.82%
2024-03-19SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
593,000
1.4693%
$0.76$447,715-33.58%
2024-03-18SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
842,020
2.0939%
$0.77$647,008-34.13%
2024-03-14SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
1.91M
0.8272%
$0.89$1.7M-37.05%
2023-02-16PurchaseSpruce Biosciences, Inc.
SPRB
10 percent owner
2.21M
0.0087%
$3.17$7M-11.16%
2022-09-14PurchaseEdgewise Therapeutics, Inc.
EWTX
10 percent owner
484,496
0.9211%
$10.32$5M-14.71%
2022-07-13SaleBolt Biotherapeutics, Inc.
BOLT
800,000
6.5259%
$2.00$1.6M-40.32%
2021-06-02SaleInogen, Inc.
INGN
10 percent owner
680,000
2.9808%
$57.32$38.98M-41.64%
2021-05-19SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
475,000
1.8365%
$13.90$6.6M-71.54%
2021-03-30PurchaseEdgewise Therapeutics, Inc.
EWTX
10 percent owner
1.25M
1.3005%
$16.00$20M-42.5%
2021-03-01SaleInogen, Inc.
INGN
10 percent owner
790,000
3.2841%
$49.00$38.71M-7.32%
2021-02-09PurchaseBolt Biotherapeutics, Inc.
BOLT
10 percent owner
400,000
32.6295%
$20.00$8M-58.82%
2020-10-20PurchaseAligos Therapeutics, Inc.
ALGS
10 percent owner
200,000
0.7223%
$15.00$3M+61.44%
2020-10-14PurchaseSpruce Biosciences, Inc.
SPRB
10 percent owner
250,000
0.9752%
$15.00$3.75M-10.92%
2020-08-21PurchaseHarmony Biosciences Holdings, Inc.
HRMY
10 percent owner
265,006
0.5848%
$24.00$6.36M-7.67%
2020-07-14PurchaseNkarta, Inc.
NKTX
10 percent owner
1.11M
1.7907%
$18.00$20M-11.28%
2020-07-08SaleCorvus Pharmaceuticals, Inc.
CRVS
10 percent owner
741,440
2.5156%
$5.37$3.99M-28.21%
2020-07-07SaleCorvus Pharmaceuticals, Inc.
CRVS
10 percent owner
796,622
2.8619%
$5.25$4.18M-22.18%
2019-11-25SaleMilestone Pharmaceuticals Inc.
MIST
10 percent owner
240,000
0.8778%
$16.00$3.84M-57.86%
Total: 41
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.